NCT07264478

Brief Summary

To understand the diagnosis and treatment status and medical burden of respiratory syncytial virus (RSV) infection in children in China, and to provide scientific basis for formulating prevention and treatment strategies for children. According to the seven administrative regions of China, namely Northeast, North, Northwest, Southwest, Central, South and East China, 1-3 children's medical institutions were selected from each region, and the cases of bronchiolitis or pneumonia admitted to hospitals and diagnosed as RSV positive by etiology during January 1, 2017 to December 31, 2021 were selected. Demographic data and clinical information were collected, and subgroup analysis was designed to explore the relationship between them and medical expenses and clinical treatment burden.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
1,100

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Oct 2022

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 15, 2022

Completed
12 months until next milestone

First Submitted

Initial submission to the registry

October 12, 2023

Completed
2.1 years until next milestone

First Posted

Study publicly available on registry

December 4, 2025

Completed
8 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 12, 2025

Completed
18 days until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2025

Completed
Last Updated

December 4, 2025

Status Verified

December 1, 2025

Enrollment Period

3.2 years

First QC Date

October 12, 2023

Last Update Submit

December 2, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • hospitalization costs

    hospitalization costs,pharmcost,testcost,testcost

    duration of hospital stay

Secondary Outcomes (1)

  • hospital day

    duration of hospital stay

Interventions

uninvolved

Eligibility Criteria

Age0 Years - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodProbability Sample
Study Population

According to the seven administrative regions of China, namely Northeast, North, Northwest, Southwest, Central, South and East China, 1-3 children's medical institutions were selected from each region, and the cases of bronchiolitis or pneumonia admitted to hospitals and diagnosed as RSV positive by etiology during January 1, 2017 to December 31, 2021 were selected. A total of 11 hospitals were selected, each with 100 children, a total of 1100 cases

You may qualify if:

  • Hospitalized patients under 18 years of age with an etiological diagnosis of RSV-positive bronchiolitis or pneumonia

You may not qualify if:

  • Inpatients under 18 years of age with an etiological diagnosis of RSV-positive bronchiolitis or pneumonia are excluded from any of the following criteria:
  • Pneumonia occurring 48 hours after hospitalization;
  • Combined with bronchial foreign body;
  • Participants in clinical trials of drugs or medical devices;
  • Not complete personal and family history and other relevant information.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Beijing Children's Hospital

Beijing, Beijing Municipality, 100045, China

Location

MeSH Terms

Conditions

Respiratory Syncytial Virus Infections

Condition Hierarchy (Ancestors)

Pneumovirus InfectionsParamyxoviridae InfectionsMononegavirales InfectionsRNA Virus InfectionsVirus DiseasesInfections

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
professor

Study Record Dates

First Submitted

October 12, 2023

First Posted

December 4, 2025

Study Start

October 15, 2022

Primary Completion

December 12, 2025

Study Completion

December 30, 2025

Last Updated

December 4, 2025

Record last verified: 2025-12

Data Sharing

IPD Sharing
Will not share

Locations